CD13 is a critical regulator of cell–cell fusion in osteoclastogenesis

Abstract

The transmembrane aminopeptidase CD13 is highly expressed in cells of the myeloid lineage, regulates dynamin-dependent receptor endocytosis and recycling and is a necessary component of actin cytoskeletal organization. Here, we show that CD13-deficient mice present a low bone density phenotype with increased numbers of osteoclasts per bone surface, but display a normal distribution of osteoclast progenitor populations in the bone marrow and periphery. In addition, the bone formation and mineral apposition rates are similar between genotypes, indicating a defect in osteoclast-specific function in vivo. Lack of CD13 led to exaggerated in vitro osteoclastogenesis as indicated by significantly enhanced fusion of bone marrow-derived multinucleated osteoclasts in the presence of M-CSF and RANKL, resulting in abnormally large cells containing remarkably high numbers of nuclei. Mechanistically, while expression levels of the fusion-regulatory proteins dynamin and DC-STAMP1 must be downregulated for fusion to proceed, these are aberrantly sustained at high levels even in CD13-deficient mature multi-nucleated osteoclasts. Further, the stability of fusion-promoting proteins is maintained in the absence of CD13, implicating CD13 in protein turnover mechanisms. Together, we conclude that CD13 may regulate cell–cell fusion by controlling the expression and localization of key fusion regulatory proteins that are critical for osteoclast fusion.

Molecular Identification of Spatially Distinct Anabolic Responses to Mechanical Loading in Murine Cortical Bone

“…The adjacent metaphyseal shell and proximal diaphyseal segment shared a similar fraction of genes as the non-adjacent metaphyseal shell and mid-diaphysis. Only four genes with established roles in bone, Fosb, (62) Tnfrsf11b, (63) Anpep, (64) and Col3a1, (65,66) were shared across all three segments.…”

Transcriptomic analysis reveals the molecular mechanisms underlying osteoclast differentiation in the estrogen-deficient pullets

“…ANPEP is a specific glycosylated type Ⅱ membrane protein highly expressed in the monocytes, macrophages, and dendritic cells. ANPEP can aid in the regulation of cell adhesion, migration, and other functions, which can control cell-cell fusion by modulating the fusion-regulatory protein in osteoclastogenesis ( Licona-Limón et al, 2015 ; Ghosh et al, 2021 ). Lower expression levels of these genes in the TRT group indicated decreased osteoclast migration and adhesion.…”

Loss of bisecting GlcNAcylation on MCAM of bone marrow stoma determined pro-tumoral niche in MDS/AML

“…MCAM plays functional roles in a variety of cellular processes, including transendothelial migration, proliferation, and cancer metastasis [43][44][45] In regard to functional mechanism, we found that MCAM on stromal cell membrane supported malignant clonal cell growth through interaction with the transmembrane aminopeptidase CD13. CD13 is frequently overexpressed in tumor cells, is involved in angiogenesis and cancer progression 52 , and is widely expressed in cells of the myeloid (HSPC) lineage 53,54 . CD13 + myeloid BM-derived cells (BMDCs) promote angiogenesis and vascular maturation by regulating pericyte recruitment through increased production of MCP-1 and MMP-9 55 .…”